These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25924832)

  • 1. Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.
    Petraroli A; Squeglia V; Di Paola N; Barbarino A; Bova M; Spanò R; Marone G; Triggiani M
    Int Arch Allergy Immunol; 2015; 166(4):259-66. PubMed ID: 25924832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.
    Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T
    Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry.
    Busse P; Bygum A; Edelman J; Lumry W; Machnig T; Martinez-Saguer I; Rojavin M
    J Allergy Clin Immunol Pract; 2015; 3(2):213-9. PubMed ID: 25609333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
    Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
    Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
    Bygum A; Andersen KE; Mikkelsen CS
    Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
    Shapiro RS; Zacek L
    J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.
    Kreuz W; Rusicke E; Martinez-Saguer I; Aygören-Pürsün E; Heller C; Klingebiel T
    Transfusion; 2012 Jan; 52(1):100-7. PubMed ID: 21756262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA; Tyson C; Relan A; Adams P; Magar R
    J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program.
    Gregory C; Landmesser LM; Corrigan L; Mariano D
    J Infus Nurs; 2014; 37(1):29-34. PubMed ID: 24384882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.
    Farkas H; Kőhalmi KV; Veszeli N; Zotter Z; Várnai K; Varga L
    Allergy Asthma Proc; 2016; 37(2):164-70. PubMed ID: 26802388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
    Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
    J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
    Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
    Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
    Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.